Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 180,880
  • Shares Outstanding, K 47,600
  • Annual Sales, $ 42,000 K
  • Annual Income, $ -64,340 K
  • 36-Month Beta 0.80
  • Price/Sales 4.31
  • Price/Cash Flow N/A
  • Price/Book 1.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.75 +10.67%
on 05/23/18
5.90 -29.66%
on 05/18/18
-0.70 (-14.43%)
since 04/25/18
3-Month
3.75 +10.67%
on 05/23/18
5.90 -29.66%
on 05/18/18
-1.60 (-27.83%)
since 02/23/18
52-Week
3.75 +10.67%
on 05/23/18
8.65 -52.02%
on 10/12/17
-0.80 (-16.16%)
since 05/25/17

Most Recent Stories

More News
Bruce Walton Named President and COO of Aurora Diagnostics

Aurora Diagnostics announced today that Bruce Walton, the company's Executive Vice President and Chief Operating Officer (COO) since January 2015, has been promoted to President and COO.

ARDX : 4.15 (+9.21%)
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018.

ARDX : 4.15 (+9.21%)
Ardelyx Inc Down 12.1% Since SmarTrend Downtrend Call (ARDX)

SmarTrend identified a Downtrend for Ardelyx Inc (NASDAQ:ARDX) on February 13th, 2018 at $5.69. In approximately 3 months, Ardelyx Inc has returned 12.13% as of today's recent price of $5.00.

ARDX : 4.15 (+9.21%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARDX , SGMO , FMI , INSY , KPTI )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SGMO : 15.60 (-4.29%)
FMI : 92.70 (+3.00%)
ARDX : 4.15 (+9.21%)
Cascade Pathology Services Practice Joins Aurora Diagnostics

Aurora Diagnostics announced today that Cascade Pathology Services Corp., a physician-owned multi-specialty pathology practice providing surgical pathology services to hospitals and physician...

ARDX : 4.15 (+9.21%)
Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc. (NASDAQ:EEFT),...

IOSP : 74.95 (-0.60%)
ALDX : 8.65 (-0.86%)
CCI : 102.74 (+0.87%)
ARDX : 4.15 (+9.21%)
ZSAN : 3.91 (-1.51%)
EEFT : 81.74 (-0.51%)
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada

Ardelyx, Inc. (NASDAQ: ARDX) today announced a license agreement with Knight Therapeutics, Inc. (TSX: GUD) (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada. Tenapanor...

GUD.TO : 8.16 (+0.25%)
ARDX : 4.15 (+9.21%)
Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors

Ardelyx, Inc. (NASDAQ: ARDX), today reported pipeline highlights and financial results for the fourth quarter and full-year ended December 31, 2017. In addition, industry-leading research expert, Jan M....

ARDX : 4.15 (+9.21%)
Consolidated Research: 2018 Summary Expectations for Progress Software, Cracker Barrel Old Country Store, Natural Grocers by Vitamin Cottage, VBI Vaccines, Ardelyx, and CytomX Therapeutics -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Progress Software Corporation...

VBIV : 3.05 (+2.01%)
NGVC : 10.71 (+1.42%)
CTMX : 26.24 (+1.20%)
CBRL : 159.92 (-0.71%)
PRGS : 37.09 (-1.83%)
ARDX : 4.15 (+9.21%)
Ardelyx Announces Departure of Chief Scientific Officer

Ardelyx, Inc. (NASDAQ: ARDX) today announced that Jeremy Caldwell, Ph.D., chief scientific officer, will be leaving the company, effective February 16, 2018, to pursue a position as chief executive officer...

ARDX : 4.15 (+9.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ARDX with:

Business Summary

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase...

See More

Key Turning Points

2nd Resistance Point 4.58
1st Resistance Point 4.37
Last Price 4.15
1st Support Level 3.87
2nd Support Level 3.58

See More

52-Week High 8.65
Fibonacci 61.8% 6.78
Fibonacci 50% 6.20
Fibonacci 38.2% 5.62
Last Price 4.15
52-Week Low 3.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar